Frankfurt - Delayed Quote EUR
Aurinia Pharmaceuticals Inc. (IKAP.F)
7.06
+0.07
+(0.97%)
At close: April 25 at 9:39:01 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
44,388
44,388
-33,461
-79,529
-157,692
Investing Cash Flow
39,262
39,262
-6,706
-60,632
-103,870
Financing Cash Flow
-49,092
-49,092
-5,130
2,433
221,112
End Cash Position
83,433
83,433
48,875
94,172
231,900
Income Tax Paid Supplemental Data
2,184
2,184
496
1,979
257
Interest Paid Supplemental Data
--
--
--
1,979
257
Capital Expenditure
-281
-281
-718
-292
-1,501
Issuance of Capital Stock
--
--
--
--
196,740
Repayment of Debt
-11,989
-11,989
-10,025
--
--
Repurchase of Capital Stock
-40,239
-40,239
--
--
--
Free Cash Flow
44,107
44,107
-34,179
-79,821
-159,193
12/31/2021 - 12/28/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade